Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · September 27, 2023

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Advanced Ovarian Cancer

The Lancet Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Oncology
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial
Lancet Oncol 2023 Sep 11;[EPub Ahead of Print], SL Aronson, M Lopez-Yurda, SN Koole, JH Schagen van Leeuwen, HWR Schreuder, RHM Hermans, IHJT de Hingh, MDJM van Gent, HJG Arts, MAPC van Ham, PA van Dam, P Vuylsteke, AGJ Aalbers, VJ Verwaal, KK Van de Vijver, NK Aaronson, GS Sonke, WJ van Driel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading